LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 10 | uM | LJP5 | 1 | M19 | 72 | hr | 513 | 829 | 10254 | 0.0808 | 0.1173 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 2 | M19 | 72 | hr | 513 | 794 | 10349 | 0.0767 | 0.1059 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 3 | M19 | 72 | hr | 513 | 696 | 10483 | 0.0664 | 0.0724 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 1 | N12 | 72 | hr | 513 | 7152 | 10537 | 0.6787 | 0.8299 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 2 | N12 | 72 | hr | 513 | 7186 | 10386 | 0.6918 | 0.8372 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 513 | 6864 | 10494 | 0.6540 | 0.8142 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 513 | 3238 | 10537 | 0.3073 | 0.5257 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 513 | 2810 | 10386 | 0.2705 | 0.4797 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 513 | 2111 | 10494 | 0.2012 | 0.3837 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 513 | 1092 | 10537 | 0.1036 | 0.1890 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 513 | 997 | 10386 | 0.0960 | 0.1653 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 513 | 972 | 10494 | 0.0926 | 0.1579 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 513 | 923 | 10537 | 0.0876 | 0.1440 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 513 | 817 | 10386 | 0.0787 | 0.1130 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 513 | 850 | 10494 | 0.0810 | 0.1228 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 513 | 919 | 10537 | 0.0872 | 0.1429 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 513 | 760 | 10386 | 0.0732 | 0.0946 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 513 | 680 | 10494 | 0.0648 | 0.0667 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 513 | 840 | 10537 | 0.0797 | 0.1196 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 513 | 833 | 10386 | 0.0802 | 0.1180 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 513 | 800 | 10494 | 0.0762 | 0.1073 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 513 | 11011 | 10254 | 1.0737 | 1.0332 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 513 | 11221 | 10349 | 1.0842 | 1.0377 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 513 | 10551 | 10483 | 1.0064 | 1.0029 |
MCF 10A | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 513 | 10605 | 10254 | 1.0342 | 1.0156 |